Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
Santiago Duro‐Sánchez(Universitat Autònoma de Barcelona), Joaquı́n Arribas(Hospital Del Mar)
Cited by 41
Related Papers
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
|Annals of Oncology|2018|424
Enhancing global access to cancer medicines
|CA A Cancer Journal for Clinicians|2020|205
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
|Nature Communications|2021|56
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
|Clinical Cancer Research|2022|22